Navigation Links
Patent Issued on Fusion-Protein Vaccine Technology
Date:2/29/2012

NEWARK, Del., Feb. 29, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering the use of iBio's proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications. The invention comprises the use of lichenase in an adjuvant-like role to improve the performance of vaccines. This approach was developed by the Fraunhofer USA Center for Molecular Biotechnology (FhCMB), iBio's research collaborator. The new patent is US Patent 8,124,103, entitled "Influenza Antigen, Vaccine Compositions, and Related Methods".

The vaccine industry is increasingly focused on the development of subunit vaccines. These subunit vaccines require use of components called adjuvants for improving their efficacy. Lichenase, when fused to antigens acts as an adjuvant and can improve the efficacy of vaccines.  Fusion of lichenase to vaccine antigens can enhance duration of immune response, improve production economies and increase product stability.  This approach could provide significant advantages over more conventional methodologies used to improve vaccine efficacy.

"We consider the issuance of this patent to be an important step in the expansion of opportunities in subunit vaccine development," said Vidadi Yusibov, Ph.D., one of the patent's inventors and Executive Director of FhCMB. "We previously published data demonstrating significant improvement in candidate vaccine performance in animal models when lichenase technology is employed with a range of target antigens, including antigens from plague, malaria, and human papilloma virus."

"While iBio's principal focus has been to optimize and commercialize our proprietary platform technology for broad commercial applications across the biologics field, we also have been bringing forward lichenase as a separate proprietary product platform to be licensed to enhance vaccine performance," said Robert B. Kay, E
'/>"/>

SOURCE iBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sigma® Life Science Obtains Global License for Kyoto Universitys iPS Cell Patent Portfolio, Deepens Commitment to Drug Discovery and ADME/Toxicology
2. Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent
3. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
4. New Patent Promises to Accelerate Cancer Trials
5. Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings
6. Prismic Pharmaceuticals Acquires Scaristas Exclusive License to Amarins Omega-3 Patents for CNS Disorders
7. IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property
8. Nautilus Neurosciences Announces New Patent Issued
9. Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex
10. Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Companys Core Technology in Oral Delivery of Proteins
11. Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Rolta gab ... Sadara Chemical Company (Sadara) erhalten zu haben, ... des integrierten Chemiekomplexes von Sadara in Jubail ... im Wert von mehreren Millionen Dollar stellt ... dessen Wert sich ebenfalls auf mehrere Millionen ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... N.C. , July 21 /PRNewswire-FirstCall / -- SPX ... completed the acquisition of the Anhydro business, a Soeborg, Denmark ... dewatering plants and equipment.  The terms of the transaction were not ... Anhydro ...
... DETROIT , July 21 Caraco Pharmaceutical ... shipping bupropion hydrochloride extended release tablets. This product was ... (FDA) for Sun Pharma,s Abbreviated New Drug Application (ANDA). ... mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline,s ...
Cached Medicine Technology:SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... Temecula Valley Southern California Wine Country, ... Wine Country artisan food and wine experiences combine ... nourishing. Savor like locals at Briar Rose, Cougar, ... EAT Marketplace, Palumbo’s Ristorante, Robin’s Nest, Old Town ... Kimberly Adams, president and CEO, Visit Temecula Valley ...
(Date:7/23/2014)... In an effort to help advance ... Disease” at the state level, the National Alliance ... of America (AFA) this week released a white ... and the need for wide-scale implementation of state plans ... The white paper outlines recommendations for both ...
(Date:7/23/2014)... living with multiple chronic medical conditions, a new study ... Health finds that the more ailments you have after ... one of the first to examine the burden of ... may help explain why increases in life expectancy among ... findings, based on an analysis of 1.4 million Medicare ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... of the AMA,board, HONOLULU, Hawaii, Nov. 13 ... Inc., has been newly elected,to the American Medical Association ... today. Mr. Kay will be the,only non-physician member on ... the position., Mr. Kay has spent his career ...
... Nov. 13 Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: ... Directors has approved the recommendation of its Special,Committee ... Nastech,s,wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent ... related to,RNA interference ("RNAi") into MDRNA. The new ...
... BOTHELL, Wash., Nov. 13 Nastech,Pharmaceutical Company ... its,corporate restructuring initiatives aimed at reducing operating expenses,and ... its,subsidiary, MDRNA, Inc., as an independent, separately financed ... Phase 2 clinical and partnered,programs as well as ...
... (SWX:,ROG.VX; RO.S) confirmed today that it has entered into ... VMSI ) and that it,will commence due diligence. Roche ... with respect to the acquisition of Ventana will be,reached. ... offer to acquire all of the,outstanding common shares of ...
... of sound in medicine has a long history. Doctors have ... human body since the early 19th century, and ultrasound imaging ... the United States typically know the gender of their offspring ... pregnancy. , Now scientists are finding many more advanced applications ...
... A gene linked to pediatric brain tumors is an essential ... of Medicine in St. Louis have found. , The study, ... neurofibromatosis 1 (NF1) gene helps push stem cells down separate ... brain cells: support cells known as astrocytes and brain neurons. ...
Cached Medicine News:Health News:Fortune 500 Executive Elected to AMA Board of Trustees 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 3Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 4Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 2Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 3Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 4Health News:Roche Confirms Commencement of Due Diligence with Ventana 2Health News:Roche Confirms Commencement of Due Diligence with Ventana 3Health News:Roche Confirms Commencement of Due Diligence with Ventana 4Health News:Sound medicine at Acoustics Meeting 2Health News:Sound medicine at Acoustics Meeting 3Health News:Sound medicine at Acoustics Meeting 4Health News:Sound medicine at Acoustics Meeting 5Health News:Sound medicine at Acoustics Meeting 6Health News:Sound medicine at Acoustics Meeting 7Health News:Sound medicine at Acoustics Meeting 8Health News:Cancer gene drives pivotal decision in early brain development 2Health News:Cancer gene drives pivotal decision in early brain development 3
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... a minimally invasive, highly effective surgical alternative ... GYNECARE TVT is positioned close to the ... when needed, TVT provides tension-free support of ... procedure takes approximately 20 to 30 minutes, ...
... best of both worlds, the PeaceKeeper ... the latest addition to the Wet-Field ... cautery instruments for ophthalmic surgery. Combining ... aspiration and backflush functionality in a ...
...
Medicine Products: